Clinical Trial Update: Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy [NA]

View source ↗

Summary

Pilot study evaluating 18F-DCFPyL PET/CT for assessing men with elevated PSA after radical prostatectomy; study status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Adenocarcinoma

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Adenocarcinoma of the Prostate | NA | Status: COMPLETED | Results posted: 2020-01-31